SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John R Resseger who wrote (2816)1/4/1999 3:09:00 PM
From: Bruce Rozenblit  Read Replies (4) of 3725
 
I agree with you 100%. But GE didn't get to be GE by throwing out money. The accountants that control buy outs just look at balance sheets, not possible growth 10 years from now. They look at revenues, capitol property, money in the bank and debt. None of these parameters amount to a hill of beans at the current condition. Business is business and GE will not pay one nickel more than they have to. Its not about being fair. Besides, GE will have to make a substantial investment in marketing and possibly redesign and tooling to get the cost down. Its just too expensive right now.

It is greatly to our advantage if Imat excels on its own, but they have lost about 10 to 15 million a year for the last 3 years and are out of dough. Beggars can't be choosers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News